MARKET

NERV

NERV

Minerva Neurosci
NASDAQ
2.120
-0.060
-2.75%
Closed 19:39 11/19 EST
OPEN
2.200
PREV CLOSE
2.180
HIGH
2.320
LOW
2.050
VOLUME
163.55K
TURNOVER
0
52 WEEK HIGH
8.80
52 WEEK LOW
1.960
MARKET CAP
105.65M
P/E (TTM)
-0.0790
1D
5D
1M
3M
1Y
5Y
1D
Minerva Neurosciences, Inc. Revises November 12, 2026 KOL Event Transcript to Clarify Regulatory Statements
NASDAQ · 3d ago
Minerva Neurosciences Revises Transcript of Roluperidone FDA Event
TipRanks · 3d ago
Weekly Report: what happened at NERV last week (1109-1113)?
Weekly Report · 4d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Minerva Neurosciences (NERV) and Moderna (MRNA)
TipRanks · 11/09 13:01
Weekly Report: what happened at NERV last week (1102-1106)?
Weekly Report · 11/09 09:54
Minerva Neurosciences GAAP EPS of -$0.19 misses by $0.01
Seeking Alpha · 11/06 15:16
Minerva Neurosciences Q3 EPS $(0.19) Beats $(0.21) Estimate
Benzinga · 11/06 14:03
*Minerva Neurosciences 3Q Loss/Shr 19c >NERV
Dow Jones · 11/06 14:00
More
About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company is involved in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and has exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson’s disease. It has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of major depressive disorder (MDD). Seltorexant is an innovative selective orexin 2 receptor antagonist. Its Roluperidone is a compound that has been shown to block serotonin, sigma, and α-adrenergic receptors that are involved in the regulation of mood, cognition, sleep and anxiety. Roluperidone has been designed to block a specific subtype of serotonin receptor called 5-HT2A.

Webull offers Minerva Neurosciences, Inc stock information, including NASDAQ: NERV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NERV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NERV stock methods without spending real money on the virtual paper trading platform.